191 related articles for article (PubMed ID: 3989325)
41. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
[TBL] [Abstract][Full Text] [Related]
42. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
[No Abstract] [Full Text] [Related]
43. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
Horiike N; Blumberg BS; Feitelson MA
J Infect Dis; 1991 Dec; 164(6):1104-12. PubMed ID: 1955710
[TBL] [Abstract][Full Text] [Related]
45. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.
Saracco G; Macagno S; Rosina F; Rizzetto M
Ann Intern Med; 1988 Mar; 108(3):380-3. PubMed ID: 3341675
[TBL] [Abstract][Full Text] [Related]
46. Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes.
Caredda F; De Franchis R; D'Arminio Monforte A; Vecchi M; Antoniozzi F; Rossi E; Primignani M; Moroni M
Boll Ist Sieroter Milan; 1984; 63(6):496-8. PubMed ID: 6534395
[TBL] [Abstract][Full Text] [Related]
47. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
Burkhardt F; Schilt U
Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
[TBL] [Abstract][Full Text] [Related]
48. Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayannis A; Smedile A; Engle R; Ticehurst JR; Feinstone SM; Purcell RH
J Med Virol; 1986 Dec; 20(4):371-9. PubMed ID: 3098915
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
50. Long-term follow-up of 60 patients with chronic hepatitis B. I. Seroconversion in the hepatitis B e-system, frequency of delta infection and histological outcome.
Lindh G; Weiland O; Svedmyr A; Glaumann H; Hansson BG
Liver; 1986 Feb; 6(1):7-12. PubMed ID: 3713454
[TBL] [Abstract][Full Text] [Related]
51. Fulminant B viral hepatitis: role of delta agent.
Govindarajan S; Chin KP; Redeker AG; Peters RL
Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
[TBL] [Abstract][Full Text] [Related]
52. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
[TBL] [Abstract][Full Text] [Related]
53. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.
Bortolotti F; Calzia R; Cadrobbi P; Giacchini R; Ciravegna B; Armigliato M; Piscopo R; Realdi G
J Pediatr; 1986 Feb; 108(2):224-7. PubMed ID: 3944707
[TBL] [Abstract][Full Text] [Related]
54. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
55. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
56. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.
Ponzetto A; Hoofnagle JH; Seeff LB
Gastroenterology; 1984 Dec; 87(6):1213-6. PubMed ID: 6092192
[TBL] [Abstract][Full Text] [Related]
57. [Role of delta infection in fulminant course of viral hepatitis].
Khlopova IN; Ketiladze ES; Farber NA
Klin Med (Mosk); 1990 Nov; 68(11):46-9. PubMed ID: 2283813
[TBL] [Abstract][Full Text] [Related]
58. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
Picciotto L; Abrescia N; Ciampi R
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
[TBL] [Abstract][Full Text] [Related]
59. Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS gene-encoded proteins.
Napoli N; Fiore G; Fera G; Modugno A; Giannelli G; Manghisi OG; Schiraldi O
Digestion; 1993; 54(1):9-14. PubMed ID: 8513991
[TBL] [Abstract][Full Text] [Related]
60. Delta infection among patients with chronic hepatitis B in the Stockholm region.
Lindh G; Weiland O; Hansson BG; Svedmyr A
Infection; 1984; 12(1):27-30. PubMed ID: 6706409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
